Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 2.26% | -18.85% | 37.18% | 19.88% | 1.48% |
| Total Depreciation and Amortization | -1.89% | -1.86% | -0.31% | -0.92% | -0.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | 5.35% | -8.30% |
| Total Other Non-Cash Items | -7.22% | -15.41% | -51.34% | 58.88% | -26.69% |
| Change in Net Operating Assets | -4.46% | 858.46% | 94.96% | -483.36% | 123.34% |
| Cash from Operations | -1.55% | 16.77% | 59.95% | -30.35% | 44.82% |
| Capital Expenditure | 100.00% | 71.43% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | 1,500.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -67.07% | 38.45% | 0.96% |
| Cash from Investing | 100.00% | -100.07% | -67.14% | 38.26% | 1.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -600.10% | 0.05% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | -- | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 100.00% | -103.02% | 122.91% | -604.97% | -1.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.04% | -142.50% | 143.02% | -1,291.43% | 134.44% |